Publications | Flatiron Health | Treatment and Testing patterns

Browse every publication tagged Treatment and Testing patterns

October 2026
Treatment patterns and survival outcomes in a real-world cohort of lutetium 177 vipivotide tetraxetan-experienced patients with metastatic castration-resistant prostate cancer
May 2026
Real-world treatment patterns and outcomes among patients with high-risk and very high-risk non-metastatic prostate cancer
- Prostate Cancer
- Treatment and Testing patterns
May 2026
Real-world second-line treatment patterns and outcomes by platinum sensitivity in extensive-stage small cell lung cancer in the post-immunotherapy era
- Lung cancer
- Treatment and Testing patterns
April 2026
Real-world clinical outcomes in patients with CLL previously treated with covalent BTKi and BCL2i regimens
- Hematologic malignancies
- Treatment and Testing patterns
April 2026
Real-world (RW) treatment patterns and outcomes in patients with =2 lines of therapy (LOTS) for recurrent or progressive endometrial cancer
- Endometrial cancer
- Treatment and Testing patterns
March 2026
Real-world clinical characteristics and treatment patterns in patients with colorectal cancer (CRC) in Japan
March 2026
Health disparities in acute myeloid leukemia patients undergoing treatment with tyrosine kinase inhibitor (TKI) therapy targeting FLT3, IDH1, or IDH2
March 2026
Impact of real-world response to first-line immunotherapy and chemotherapy on subsequent treatment outcomes in patients with advanced or metastatic non-small cell lung cancer
- Lung cancer
- Treatment and Testing patterns
February 2026
Real-world (rw) first-line (1L) treatment (tx) patterns and overall survival (rwOS) in patients (pts) with locally advanced/metastatic urothelial carcinoma (la/mUC) with frailty or comorbidities
- Bladder cancer
- Treatment and Testing patterns